U.S. pharma giant copyright scrapped two experimental weight loss supplements last calendar year—a the moment-every day capsule, lotiglipron, due to elevated liver enzymes and also a 2 times-day-to-day tablet, danuglipron, because of sturdy Unwanted effects—but CEO Albert Bourla has claimed the company is set to “play and win” within the ob